NSB ASX · Health Care

Neuroscientific Biopharmaceuticals Ltd

Announcements, last 12 months: 35
Price sensitive, last 12 months: 12
Followed on InvestorPA: Low (Outside the 20% most-followed companies on InvestorPA)

Latest announcements

Released	Headline	Actions
22 Oct 2026, 9:31 AM	Appointment of CFO
15 Oct 2026, 1:52 PM	Results of Annual General Meeting
13 Oct 2026, 9:31 AM	US FDA Provides Positive Feedback on Planned Phase 2 Trial
1 Oct 2026, 9:38 AM	Leading CRO Appointed for Phase 2 Crohn's Trial Price sensitive
8 Sep 2026, 3:59 PM	Notice of Annual General Meeting & Proxy Form
8 Sep 2026, 3:33 PM	Letter to Shareholders & Proxy Form
4 Sep 2026, 1:55 PM	Resignation and Appointment of Auditor
25 Aug 2026, 5:55 PM	Appendix 4G & Corporate Governance Statement
25 Aug 2026, 5:52 PM	2026 Annual Report & Appendix 4E Price sensitive	AI summary
13 Aug 2026, 8:22 AM	Pre-IND Meeting with US FDA Scheduled

Guidance history

30 Jan 2026

The company did not provide any high-importance, price-sensitive forward-looking financial metrics in the announcement.

Most followed in Health Care

PME Pro Medicus Ltd
AHC Austco Healthcare Ltd
CSL CSL Ltd
RMD Resmed Inc
TLX TELIX Pharmaceuticals Ltd
CGS Cogstate Ltd
ALC Alcidion Group Ltd
CSX Cleanspace Holdings Ltd

Follow NSB to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.